Myofibroblast activation of Valvular Interstitial Cells (VICs) is considered to be a primary driver of valvular fibrosis and stenosis. For this reason, the external cues that act to control the myofibroblast phenotype of VICs have been topics of considerable attention in the field. Increasing evidence suggests that beyond receptor-mediated activation of VICs by soluble growth factors, physical cues from the matrix play a critical role in this process. Unfortunately, traditional methods used to culture VICs inherently leads to their myofibroblast activation, such that it becomes difficult to determine the effects of environmental stiffness on activation and especially de-activation. To address this issue, our group has demonstrated that unique hydrogel materials can be used to create soft, non-activating substrates for VIC culture that allow VICs to maintain a phenotype that more closely resembles that of freshly isolated cells. Now, we aim to examine how matrix stiffness in combination with pro-inflammatory cytokines influence the VIC fibroblast-to- myofibroblast transition, the epigenetic changes that may occur to these cells over time, and the pathways in matrix signaling that might be useful in reversing the pathogenic myofibroblast phenotype. Specifically, we propose to: 1) Use a combinatorial approach to study the effect of pro-inflammatory cytokines on VIC phenotypes as a function of microenvironmental stiffness 2) Identify the effects of mechanical and inflammatory cues on the fibroblast-to-myofibroblast transition and its reversal using hydrogels with dynamically tunable mechanical properties, and 3) Discover new molecular targets for therapeutics to temper pathogenic VIC myofibroblast activation under inflammatory conditions. Together, work completed within each of these Aims will provide unique insight into the progression of fibrotic aortic valvular stenosis. The creation of tunable cell culture platforms will allow us to answer questions about differences between reversible (transient, wound healing state) and irreversible (persistent, pathogenic state) VIC myofibroblasts that cannot be adequately addressed with traditional methods. Subsequent analysis of the signaling pathways and genes will be used to identify new targets with therapeutic potential to reverse VIC activation and treat valve disease. Moreover, successful completion of these Aims should be of general interest to the field of medicine, as mechanisms of fibrosis are likely shared among most fibrosis-related diseases.

Public Health Relevance

We aim to explore the role of dynamic microenvironmental cues from both inflammatory cytokines and mechanical signaling on the progression of heart valve disease. We will develop and use tunable material systems that can modulate matrix cues in the presence of encapsulated valvular interstitial cells, the main cell population found in heart valves, and subsequently characterize their fibroblast-to-myofibroblast transition. This knowledge will then be used to provide important insight into methods to target therapeutic treatments that may delay the progression of or even reverse valve fibrosis/disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL132353-03
Application #
9608064
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Evans, Frank
Project Start
2016-12-15
Project End
2020-11-30
Budget Start
2018-12-01
Budget End
2019-11-30
Support Year
3
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Colorado at Boulder
Department
Engineering (All Types)
Type
Biomed Engr/Col Engr/Engr Sta
DUNS #
007431505
City
Boulder
State
CO
Country
United States
Zip Code
80303
Aguado, Brian A; Grim, Joseph C; Rosales, Adrianne M et al. (2018) Engineering precision biomaterials for personalized medicine. Sci Transl Med 10:
Grim, Joseph C; Brown, Tobin E; Aguado, Brian A et al. (2018) A Reversible and Repeatable Thiol-Ene Bioconjugation for Dynamic Patterning of Signaling Proteins in Hydrogels. ACS Cent Sci 4:909-916
Peña, Brisa; Bosi, Susanna; Aguado, Brian A et al. (2017) Injectable Carbon Nanotube-Functionalized Reverse Thermal Gel Promotes Cardiomyocytes Survival and Maturation. ACS Appl Mater Interfaces 9:31645-31656
Brown, Tobin E; Anseth, Kristi S (2017) Spatiotemporal hydrogel biomaterials for regenerative medicine. Chem Soc Rev 46:6532-6552
Ma, Hao; Killaars, Anouk R; DelRio, Frank W et al. (2017) Myofibroblastic activation of valvular interstitial cells is modulated by spatial variations in matrix elasticity and its organization. Biomaterials 131:131-144
Rosales, Adrianne M; Anseth, Kristi S (2016) The design of reversible hydrogels to capture extracellular matrix dynamics. Nat Rev Mater 1:
Mabry, Kelly M; Lawrence, Rosa L; Anseth, Kristi S (2015) Dynamic stiffening of poly(ethylene glycol)-based hydrogels to direct valvular interstitial cell phenotype in a three-dimensional environment. Biomaterials 49:47-56